Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 105175
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.105175
Table 1 Screening, intervention, evaluation schedule
Item
Before treatment (within 2 weeks)
Each treatment cycle
End of treatment or withdrawal
Collection of basic information
Admission screening form×--
Signing the informed consent form×--
Baseline information×--
Effectiveness index
CT/MRI1×Every 2 months or at a time point deemed appropriate by the investigator×
Tumor marker2×××
Safety indicator
Blood pressure××-
Blood routine××-
Blood coagulation function××-
Thyroid gland function×Every 2 months or at a time point deemed appropriate by the investigator-
24-hour urinary protein quantification×Every 2 months or at a time point deemed appropriate by the investigator-
Liver and kidney function××-
ECG××-
Echocardiogram××-
Urinalysis××-
Stool routine + occult blood××-
Recording adverse events-××